Knockdown of Long Noncoding RNA Plasmacytoma Variant Translocation 1 with Antisense Locked Nucleic Acid GapmeRs Exerts Tumor-Suppressive Functions in Human Acute Erythroleukemia Cells Through Downregulation of C-MYC Expression

Cancer Biotherapy & Radiopharmaceuticals
Mahsa SalehiMarzieh Bagheri

Abstract

Objective: Acute erythroleukemia (AEL) is a subtype of acute myeloid leukemia (AML), with no specific treatment. Up- or downregulation of long noncoding RNAs (lncRNAs) is strongly associated with the formation and progression of many malignancies. Plasmacytoma variant translocation 1 (PVT1) is a significantly upregulated lncRNA in AML. Antisense locked nucleic acid (LNA) GapmeRs oligonucleotides are the novel tools for targeting lncRNAs. The purpose of the current study was to investigate the functional role of PVT1 antisense LNA GapmeRs on AEL cell line (KG-1). Materials and Methods: AEL cells were transfected with PVT1 antisense LNA GapmeRs at three different time points. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) was accomplished to evaluate the PVT1 expression by PVT1 antisense LNA GapmeRs. The viability was evaluated by MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide) assay, and the apoptosis and necrosis were assessed by Annexin V/propidium iodide staining assay. The C-MYC expression level, the target gene of PVT1, was also quantified by qRT-PCR. Results: The results indicated that PVT1 inhibition could significantly decrease the viability of AEL cells, due to inductio...Continue Reading

References

Nov 28, 2006·Lancet·Elihu Estey, Hartmut Döhner
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yinghui GuanJoe W Gray
Apr 25, 2008·Blood Reviews·Chad M Craig, Gary J Schiller
Feb 15, 2011·Biochemical and Biophysical Research Communications·Lei YouYu-Pei Zhao
Mar 26, 2013·American Journal of Hematology·Elihu H Estey
Jun 4, 2013·Journal of Hematology & Oncology·Hua ZhangYueqin Chen
Jul 22, 2014·Nature·Yuen-Yi TsengAnindya Bagchi
Jul 22, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fang WangShu-Han Sun
Aug 28, 2014·Biochimica Et Biophysica Acta·Guodong YangLijun Yuan
Dec 24, 2014·Molecular Genetics and Metabolism·Kathleen M SakamotoElizabeth A Eklund
Apr 18, 2015·BioMed Research International·Teresa ColomboPaola Paci
May 10, 2015·Biochemical and Biophysical Research Communications·Xian-wen ZhangJun Li
Sep 17, 2015·The New England Journal of Medicine·Hartmut DöhnerClara D Bloomfield
Nov 28, 2015·Briefings in Functional Genomics·Norma I Rodríguez-Malavé, Dinesh S Rao
Dec 25, 2015·Genes & Development·Gayatri ArunDavid L Spector
Dec 29, 2015·Medical Oncology·Fatemeh JalaliRasoul Salehi
Feb 7, 2016·Biochemical and Biophysical Research Communications·Ming CuiYupei Zhao
Mar 26, 2016·Pharmacology & Therapeutics·Mansi A ParasramkaTushar Patel
May 29, 2016·Molecular Cancer·Nenad BartonicekMarcel E Dinger
Apr 1, 2015·Molecular & Cellular Oncology·Yuen-Yi Tseng, Anindya Bagchi
Jul 26, 2016·Oncology Letters·Rui ZhangJin-Shui Zhu
Sep 25, 2016·Methods in Molecular Biology·Benoit T RouxJames A Heward
Dec 16, 2016·International Journal of Molecular Sciences·Armin ZebischHeinz Sill

❮ Previous
Next ❯

Citations

Apr 21, 2020·Phytotherapy Research : PTR·Mahsa SalehiHamed Mirzaei
May 15, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A GhadiriP Bagheri
Mar 3, 2020·Frontiers in Oncology·Onayemi Titilayo OnagoruwaOlorunseun O Ogunwobi
Jul 2, 2020·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Beili ChenQin Zhou
Aug 6, 2019·Frontiers in Oncology·Wenxi WangZhaoyang Zeng
May 28, 2019·Journal of Hematology & Oncology·Yan LiuLin Fu
Jul 6, 2020·Annals of Hematology·Leonidas BenetatosGeorgios Vartholomatos
May 1, 2021·International Journal of Molecular Sciences·Tushar Singh BarwalAklank Jain
May 19, 2021·Cold Spring Harbor Perspectives in Biology·Tasha A MorrisonJohn J O'Shea

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
PCR
flow cytometry
fluorescence microscopy

Software Mentioned

CellQuest
SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.